Parallel Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.5M | Buy |
16,366
+3,742
| +30% | +$574K | 0.05% | 259 |
|
|
2025
Q4 | $1.74M | Buy |
12,624
+148
| +1% | +$19.4K | 0.03% | 318 |
|
|
2025
Q3 | $1.6M | Buy |
12,476
+351
| +3% | +$42.8K | 0.03% | 324 |
|
|
2025
Q2 | $1.47M | Sell |
12,125
-706
| -6% | -$79.6K | 0.03% | 329 |
|
|
2025
Q1 | $1.43M | Sell |
12,831
-1,586
| -11% | -$169K | 0.03% | 323 |
|
|
2024
Q4 | $1.4M | Buy |
14,417
+496
| +4% | +$52.9K | 0.03% | 314 |
|
|
2024
Q3 | $1.6M | Buy |
13,921
+975
| +8% | +$111K | 0.04% | 284 |
|
|
2024
Q2 | $1.38M | Buy |
12,946
+896
| +7% | +$89.9K | 0.04% | 292 |
|
|
2024
Q1 | $1.17M | Buy |
12,050
+3,179
| +36% | +$326K | 0.03% | 331 |
|
|
2023
Q4 | $896K | Sell |
8,871
-235
| -3% | -$22.7K | 0.03% | 359 |
|
|
2023
Q3 | $928K | Buy |
9,106
+298
| +3% | +$30.2K | 0.03% | 326 |
|
|
2023
Q2 | $889K | Buy |
8,808
+762
| +9% | +$76.2K | 0.03% | 338 |
|
|
2023
Q1 | $740K | Buy |
8,046
+705
| +10% | +$61.6K | 0.03% | 369 |
|
|
2022
Q4 | $666K | Sell |
7,341
-63
| -0.9% | -$5.31K | 0.03% | 339 |
|
|
2022
Q3 | $563K | Sell |
7,404
-771
| -9% | -$63.9K | 0.03% | 359 |
|
|
2022
Q2 | $691K | Sell |
8,175
-2,138
| -21% | -$188K | 0.03% | 314 |
|
|
2022
Q1 | $907K | Sell |
10,313
-1,684
| -14% | -$146K | 0.04% | 288 |
|
|
2021
Q4 | $1.05M | Sell |
11,997
-1,900
| -14% | -$158K | 0.04% | 261 |
|
|
2021
Q3 | $1.14M | Buy |
13,897
+2,123
| +18% | +$191K | 0.05% | 240 |
|
|
2021
Q2 | $1.07M | Buy |
11,774
+3,484
| +42% | +$310K | 0.05% | 244 |
|
|
2021
Q1 | $709K | Buy |
8,290
+486
| +6% | +$43.6K | 0.03% | 291 |
|
|
2020
Q4 | $737K | Buy |
7,804
+157
| +2% | +$13.7K | 0.04% | 257 |
|
|
2020
Q3 | $665K | Buy |
7,647
+834
| +12% | +$72.3K | 0.04% | 248 |
|
|
2020
Q2 | $595K | Buy |
6,813
+1,438
| +27% | +$124K | 0.04% | 262 |
|
|
2020
Q1 | $443K | Sell |
5,375
-1,338
| -20% | -$119K | 0.04% | 273 |
|
|
2019
Q4 | $636K | Buy |
6,713
+65
| +1% | +$5.83K | 0.05% | 249 |
|
|
2019
Q3 | $578K | Buy |
6,648
+1,603
| +32% | +$144K | 0.05% | 246 |
|
|
2019
Q2 | $461K | Sell |
5,045
-468
| -8% | -$39.6K | 0.05% | 254 |
|
|
2019
Q1 | $475K | Buy |
5,513
+1,561
| +39% | +$125K | 0.05% | 225 |
|
|
2018
Q4 | $303K | Buy |
3,952
+747
| +23% | +$58.1K | 0.04% | 275 |
|
|
2018
Q3 | $247K | Buy |
3,205
+65
| +2% | +$4.8K | 0.03% | 341 |
|
|
2018
Q2 | $212K | Sell |
3,140
-1,166
| -27% | -$80.5K | 0.03% | 337 |
|
|
2018
Q1 | $312K | Buy |
4,306
+130
| +3% | +$9.9K | 0.05% | 245 |
|
|
2017
Q4 | $314K | Buy |
4,176
+62
| +2% | +$4.68K | 0.05% | 244 |
|
|
2017
Q3 | $305K | Buy |
4,114
+14
| +0.3% | +$1.06K | 0.05% | 248 |
|
|
2017
Q2 | $313K | Buy |
4,100
+511
| +14% | +$36.2K | 0.06% | 242 |
|
|
2017
Q1 | $250K | Sell |
3,589
-1,017
| -22% | -$67.8K | 0.05% | 257 |
|
|
2016
Q4 | $301K | Buy |
+4,606
| New | +$299K | 0.07% | 192 |
|
Other funds holding NVS
Parallel Advisors's NVS Position: Q1 2026 in Review
Parallel Advisors increased its Novartis (NVS) stake by 30% in Q1 2026, buying an estimated $574K and bringing the position to 16,366 shares worth $2.5M. The position accounts for 0.05% of the portfolio, ranked #259.
Parallel Advisors first reported a position in NVS in Q4 2016 and has held it in 38 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Parallel Advisors held 16,366 shares of Novartis worth $2.5M as of Q1 2026.
- Parallel Advisors bought 3,742 Novartis shares in Q1 2026, an estimated $574K.
- Novartis made up 0.05% of Parallel Advisors's portfolio in Q1 2026, its #259 holding.
- Parallel Advisors first reported a position in Novartis in Q4 2016 and has held it in 38 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.